A detailed history of Palumbo Wealth Management LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Palumbo Wealth Management LLC holds 15,065 shares of DVAX stock, worth $159,387. This represents 0.05% of its overall portfolio holdings.

Number of Shares
15,065
Previous 32,397 53.5%
Holding current value
$159,387
Previous $420,000 64.52%
% of portfolio
0.05%
Previous 0.15%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 15, 2025

SELL
$9.4 - $12.87 $162,920 - $223,062
-17,332 Reduced 53.5%
15,065 $149,000
Q1 2025

Apr 22, 2025

BUY
$12.39 - $14.4 $134,604 - $156,441
10,864 Added 50.45%
32,397 $420,000
Q4 2024

Jan 30, 2025

BUY
$10.28 - $13.66 $221,359 - $294,140
21,533 New
21,533 $274,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.34B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Palumbo Wealth Management LLC Portfolio

Follow Palumbo Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Palumbo Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Palumbo Wealth Management LLC with notifications on news.